Benign prostatic hyperplasia Posts on Medivizor
Navigation Menu

Benign prostatic hyperplasia Posts on Medivizor

An overview of urinary symptoms in Parkinson disease and multiple system atrophy

Posted by on Jul 11, 2017 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study summarized the occurrence and treatment of urinary symptoms in patients with Parkinson disease (PD) and multiple system atrophy (MSA). Some background Urinary incontinence is a bothersome symptom that can have a considerably impact on quality of life. It can have various causes, including disorders of the central nervous...

Read More

Tamsulosin, dutasteride and imidafenacin – a promising new treatment combination for BPH

Posted by on Jul 11, 2017 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study examined the effects of combining 3 different types of therapies – tamsulosin (Flomax), dutasteride (Avodart), and imidafenacin (Uritos) – in the treatment of benign prostatic hyperplasia (BPH). Authors concluded that this treatment combination is safe and effective in reducing urinary symptoms caused by BPH. Some...

Read More

Severe urinary symptoms are associated with increased cardiovascular risk

Posted by on Jul 11, 2017 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study examined the association between cardiovascular disease (CVD) and the presence of urinary symptoms. Researchers reported a significant increase in the 10-year CVD risk among men with severe urinary symptoms, after controlling for other risk factors. Some background The occurrence and symptoms of benign prostatic...

Read More

Two-year outcomes following convective radiofrequency water vapor thermal therapy for BPH

Posted by on Jun 14, 2017 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study examined the 2-year outcomes in men who underwent convective therapy for benign prostatic hyperplasia (BPH). This study concluded that this minimally invasive procedure was safe and continued to be effective after 2 years. Some background Medications are often the first choice of treatment for men with BPH and lower...

Read More

Prostate protrusion into the bladder predicts treatment success with dutasteride

Posted by on Mar 13, 2017 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study examined factors that affect treatment outcomes with dutasteride (Avodart) for benign prostatic hyperplasia (BPH). Researchers reported that the amount that the prostate protruded into the bladder before treatment was the strongest predictor of treatment success. Some background An enlarged prostate can protrude into the...

Read More

Aquablation: Early results of a promising minimally invasive procedure for BPH

Posted by on Feb 6, 2017 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study examined the effects of aquablation, a new procedure to treat urinary symptoms due to benign prostate hyperplasia (BPH). Researchers reported significantly improved urinary symptoms with few treatment-related side effects following aquablation. Some background BPH can lead to bothersome urinary symptoms that impact quality...

Read More

Examining infection rates after HoLEP: a minimally invasive procedure for BPH

Posted by on Jan 17, 2017 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study examined the rate of infection associated with Holmium laser enucleation of the prostate (HoLEP), a minimally invasive procedure to treat benign prostatic hyperplasia (BPH). Authors concluded that HoLEP was associated with a low rate of infection. Some background BPH can lead to bothersome urinary symptoms and surgery is...

Read More

Minimally invasive procedure for BPH: The effect of the patient’s health on number of side effects

Posted by on Jan 2, 2017 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study examined the effect of the patient’s health and number of medical conditions on the occurrence of side effects after transurethral resection of the prostate (TURP). Researchers concluded that these did not affect the occurrence of side effects after TURP. Most complications after TURP were considered mild.   Some...

Read More

Avodart and propecia: Examining sexual side effects of 5-alpha reductase inhibitors

Posted by on Jan 2, 2017 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study examined the effect of 5-alpha reductase inhibitors (5ARIs) on sexual function. In an analysis of many studies, researchers reported an increased risk of sexual side effects in men receiving 5ARIs for benign prostatic hyperplasia (BPH). Some background Drugs that are commonly prescribed for treating urinary symptoms in BPH...

Read More

Comparing reduction in prostate size between two minimally invasive procedures for BPH

Posted by on Dec 19, 2016 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study compared outcomes of two minimally invasive surgical procedures used to treat benign prostatic hyperplasia (BPH). Researchers concluded that the recently developed transurethral bipolar plasma vaporization of the prostate (BPV) showed comparable treatment outcomes to the current standard-of-care. Some background BPH can...

Read More